See up to 3 months of NXTC. The 7-day demo opens the 1M and 3M ranges and puts NXTC on your watchlist.
Start 7-day demoLatest NXTC insider trades
About NextCure, Inc. (NXTC)
NextCure, Inc. files with the SEC under CIK 0001661059 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
NXTC Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 13 | 346,761 | $1.71M |
| Open-market sale | 1 | 30,000 | $185K |
NXTC insider transactions (Form 4)
2817 Form 4 filings on record, the earliest from Jun 20, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Simcere Zaiming, Inc. | Open-market sale | Common Stock | 30,000 | $6.16 | $185K | |
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Stock | 50,000 | $4.97 footnote F1 | $249K | |
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Stock | 20,000 | $5.00 | $100K | |
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Stock | 20,000 | $5.00 | $100K | |
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Stock | 25,000 | $4.81 footnote F2 | $120K | |
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Stock | 100,000 | $4.90 | $490K | |
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Stock | 77,850 | $4.96 footnote F3 | $386K | |
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Stock | 3,300 | $4.98 footnote F4 | $16K | |
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Stock | 25,000 | $4.98 footnote F5 | $125K | |
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Stock | 8,003 | $4.80 | $38K | |
| ||||||
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Stock | 7,798 | $5.00 | $39K | |
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Stock | 6,400 | $4.95 footnote F1 | $32K | |
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Stock | 1,810 | $5.00 | $9K | |
| ADAR1 Capital Management, LLC - 10% Owner | Open-market purchase | Common Stock | 1,600 | $5.00 | $8K | |
| ||||||
| Elaine V. Jones | Grant or award | Stock Option (Right to Buy) | 2,340 | $0.00 | - | |
| Ellen Feigal | Grant or award | Stock Option (Right to Buy) | 2,340 | $0.00 | - | |
| Anne Elizabeth Borgman | Grant or award | Stock Option (Right to Buy) | 2,340 | $0.00 | - | |
| Stephen W. Webster | Grant or award | Stock Option (Right to Buy) | 2,340 | $0.00 | - | |
| David S. Kabakoff | Grant or award | Stock Option (Right to Buy) | 3,510 | $0.00 | - | |
| John G. Houston | Grant or award | Stock Option (Right to Buy) | 2,340 | $0.00 | - | |
| Kevin G. Shaw - Officer | Grant or award | Employee Stock Option (Right to Buy) | 8,270 | $0.00 | - | |
| Sourav Kundu - Officer | Grant or award | Employee Stock Option (Right to Buy) | 8,270 | $0.00 | - | |
| Udayan Guha - Officer | Grant or award | Employee Stock Option (Right to Buy) | 14,670 | $0.00 | - | |
| Timothy Mayer - Officer | Grant or award | Employee Stock Option (Right to Buy) | 14,670 | $0.00 | - | |
| Michael Richman - Officer | Grant or award | Employee Stock Option (Right to Buy) | 38,190 | $0.00 | - | |
 Steven P. Cobourn - Officer | Grant or award | Employee Stock Option (Right to Buy) | 14,670 | $0.00 | - | |
| Elaine V. Jones | Grant or award | Stock Option (Right to Buy) | 18,700 | $0.00 | - | |
| David S. Kabakoff | Grant or award | Stock Option (Right to Buy) | 28,050 | $0.00 | - | |
Item 8.01, 9.01
Item 1.01, 9.01
Item 2.02, 9.01
Item 1.01, 2.05, 5.01, 5.02, 7.01, 8.01, 9.01
NXTC insider trading FAQ
What is the latest insider trade for NXTC?
NextCure, Inc. (NXTC) had 3 insider filings in the last 90 days, with the most recent on 2026-08-12. The full record for NXTC runs to 17 Form 4 filings, the earliest from 2025-06-20. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying NXTC stock?
13 insider purchases of NXTC were filed in the last 90 days, totaling $1.71M.
How many insiders are selling NXTC stock?
1 insider sale of NXTC was filed in the last 90 days, totaling $185K.
Where can I see NXTC SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects NXTC Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Simcere Zaiming, Inc. view on EDGAR
- - ADAR1 Capital Management, LLC view on EDGAR
- - ADAR1 Capital Management, LLC view on EDGAR
- - Elaine V. Jones view on EDGAR
- - Ellen Feigal view on EDGAR
- - Anne Elizabeth Borgman view on EDGAR
- - Stephen W. Webster view on EDGAR
- - David S. Kabakoff view on EDGAR
- - John G. Houston view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where NXTC's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow NXTC with a 7-day demo
- NXTC on your watchlist
- Every NXTC Form 4 filing on record
- Up to 3 months of NXTC price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
